Buy Durolane 60mg – 3ml online wholesale. Durolane 60mg – 3ml is a hyaluronic acid is a single injection. It is based upon a natural, safe and proven technology called NASHA®. Hyaluronic acid (HA) is a naturally occurring molecule that provides the lubrication and cushioning in a normal joint. This treatment relieves the pain of osteoarthritis (OA) in specific small and large joints.

The stabilized form of HA in DUROLANE is known as NASHA. For the symptomatic treatment of mild to moderate knee or hip osteoarthritis.

Benefits of DUROLANE®

•Directly treats the affected joint

•Treatment is repeatable as required by your physician

•May help to avoid or delay hip or knee replacement surgery

•Long-term freedom from osteoarthritis pain

•Simple & quick to administer

•Drug-free alternative to pills

Packaging

•1 x 60mg/3ml

DUROLANE (3 mL): Argentina, Australia,* Brazil, Chile, Colombia, EU,* India, New Zealand,* Russia, Switzerland,* Turkey,* United Arab Emirates: Symptomatic treatment of mild to moderate knee or hip osteoarthritis. In addition, DUROLANE has been approved in Australia, EU and New Zealand for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, shoulder, elbow, wrist, fingers, and toes.

Mexico: Symptomatic treatment of mild to moderate knee osteoarthritis.

Taiwan: Treatment of pain in OA of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. In addition, DUROLANE has been licensed for the symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, fingers and toes.

*DUROLANE is also indicated for pain following joint arthroscopy in the presence of osteoarthritis within 3 months of the procedure.

Full prescribing information can be found in product labeling.

Summary of risks: You should not use DUROLANE if you have infections or skin disease at the injection site. DUROLANE has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling.

Summary of Indications for Use for Curavisc: Curavisc (2 mL): EU, Brazil, Egypt, Malaysia: Pain and disturbed function in degenerative and traumatic disease of the joints. Curavisc can be used for large joints, e.g., knee, hip, or shoulder joint. Treatment course of 3- injections, up to 5- injections.

Summary of risks: You should not use CURAVISC if you have infections or skin disease at the injection site. CURAVSIC has not been tested in pregnant or lactating women, or children. Risks can include transient pain, swelling and/ or stiffness at the injection site.

Full prescribing information can be found on the product labeling and on the website at bioventus.com/curavisc.com.